Kiddo

Kiddo's business model is centered on providing a comprehensive connected care system for at-risk children with chronic conditions such as asthma, diabetes, autism, and congenital heart disorders. The company partners with health systems, benefits providers, pediatric hospitals, and foundations, including major players like UHC/Optum and PC Health. Revenue is generated by enabling healthcare providers to receive reimbursements through various medical billing codes related to remote patient monitoring and chronic care management.

The core of Kiddo's offering is a wrist-worn wearable device designed for children aged 3 to 10. This device is equipped with five clinical-grade sensors that track key vitals, including heart rate, skin temperature, blood oxygen levels (SPO2), perspiration, and motion. The collected data is transmitted in real-time to a companion mobile application for parents and caregivers, providing daily health insights, alerts, and recommendations. The platform is HIPAA, HL7, and FHIR compliant, ensuring data security and interoperability with existing healthcare systems like EMRs and telehealth platforms. Beyond simple monitoring, the platform includes a coaching app for parents, on-demand telehealth services, and a clinical decision support tool for physicians to adjust treatment protocols based on real-world data. In 2022, Kiddo announced a $16 million Series A funding round to expand its teams, enhance partnerships, and pursue FDA device certification.